MDM2 and Merkel cell skin cancer: This assertion suggests that even without the helicase domain, LTT would activate p53 in MCC cells, but the investigators propose that the sT-MYC-EP400 transcriptional complex counteracts p53 activity through upregulation of MDM2 and the related enzyme MDM4 (Park et al., 2019).